The presentation is analysis of APIs (Active Pharmaceuticals Ingredients) manufactured in India, it can help to choose products for development and setting up marketing strategies for APIs in domestic and overseas market.
The analysis has covered detailed analysis of more than 1500 APIs manufactured in India.
2. WORLD OF APIs
• Globally there are over 7000 APIs are active in 2013
• Altogether APIs creates USD 120 billion world market
• Which is 12% of world pharmaceuticals market
• That is around USD 1000 billion
• World market of APIs is growing at the rate of 8%
• US is biggest market with around 45% share of the world
market
3. INDIAN APIs INDUSTRY
• India has around 2300 APIs manufacturing units
•Which produces around 1500 APIs
•For domestic and International market
•Indian APIs Industry is worth USD 9 billion in 2013
•Out of which USD 5 billion exported across the world
•Rest USD 4 billion goes for formulation
•Out of which USD 2 billion goes for the formulation for
export
•Rest USD 2 billion goes for domestic formulation
manufacturing
4. INDIAN APIs INDUSTRY: ASSUMPTIONS
• The basis of the study is export data of APIs and
formulations and articles published in different journals
for the year 2012-13
• The export data suggest USD 5 billion worth APIs goes
for export we assume the domestic consumption (for
domestic and export formulation) is USD 4 billion or
80% of the export business
• It must be noted that while USD 2 billion APIs results in
USD 10 billion export of formulation while the same
value of APIs creates USD 18-20 billion Indian domestic
formulation markets
5. INDIAN APIs INDUSTRY
• Out of 1500 APIs produced in India around 1000 goes
for export
• Top 50 APIs contributes 50% of the industry
• Top 100 APIs accounts for 70% of the industry
• Top 200 APIs constitutes 85 % of the industry
• Top 500 APIs represents 95% of the industry
6. The TOP 500 APIs
• Top 500 APIs accounts for 95% of business
• But the study leaves some APIs which does more than USD
5 million in export of formulation like ---
DIDANOSINE, MUPIROCIN, CYCLOSERINE,
IPRATROPIUM, ZIPRASIDOE, WARFARINSODIUM,
GENTAMICIN,BECLOMETHASONE, IRINOTECAN,
ZONISAMIDE, MISOPROSTOL, INDAPAMIDE,
AMYLMETACRESOL, LEVODOPA, ATRACURIUM,
RILUZOLE, PROPOFOL, ISOTRETINOIN,
OXALIPLATIN, LEVONORGESTREL, ZAFIRLUKAST,
ALPRAZOLAM, TROSPIUMCHLORIDE, AZELASTINE,
DOXORUBICIN, VECURONIUM, ESTRADIOL,
NORETHINDRONE, FONDAPARINUX, ETOMIDATE,
CEVIMELINE, OCTREOTIDE, ETHINYLESTRADIOL,
RITUXIMAB, TIAGABINE, and NORGESTIMATE and
7. THE MILLION DOLLAR CLUB
• There are 430 APIs whose export is above USD 1 Million
• The club represents 93% of the Industry
• We further filter the list and leave APIs whose average price
is below USD 25/kg and that leaves few major products
whose export is considerable like----
NAPROXEN, SALICYLIC ACID, TRICLOSAN, ERYTHROMYCIN,
RANITIDINE, POVIDONE IODINE, COTRIMOXAZOLE,
CAFFEINE, DICLOFENAC, METRONIDAZOLE, PERMETHRIN,
GUAIFENESIN, SULFAMETHOXAZOLE, NICOTINAMIDE,
CHLORHEXIDINE, ACETAMINOPHEN, METFORMIN, NIACIN,
GLYCINE, BENZYL CHLORIDE, CLOXACILLIN, ZINCOXIDE,
AMPICILLIN, CALCIUM CARBONATE and ALUMINIUM
HYDROXIDE
8. THE MILLION DOLLAR CLUB…
• Now we are left with 355 APIs for our analysis
• Which represents around 75% of the industry
• Further we eliminate the APIs whose export is less than
500 Kg
• And that leaves some valued products like
ROCURONIUM, TACROLIMUS, FIDAXOMICIN,
ADAPALENE and SIROLIMUS
• Now we are have left with 320 APIs which represents
70% of the industry
• AND THAT IS THE BASIS OF INDIAN APIs
ANALYSIS
9. THERAUPEUTICAREAS/CATEGOREIS
• ANTI-INFECTIVES
• CARDIOVASCULAR & HEMATOPOIETIC SYSTEM
• CENTRAL NERVOUS SYSTEM
• ENDOCRINE & METABOLIC SYSTEM
• GASTROINTESTINAL & HEPATOBILIARY SYSTEM
• GENITO-URINARY SYSTEM
• MUSCULO-SKELETAL SYSTEM
• ONCOLOGY
• RESPIRATORY SYSTEM
• OTHERS: DERMATOLOGICALS, ALLERGY & AMMUNE SYSTEM, EAR &
MOUTH/THROAT, EYE, HORMONES, NUTRITION, VITAMINS &
MINERALS, ANAESTHETICS - LOCAL & GENERAL,VETERINARY
DRUGS
10. THERAPEUTIC SEGMENTS SHARE
Therapeutica Areas Industry
Share in %
ANTI-INFECTIVES 32.65
CARDIOVASCULAR & HEMATOPOIETIC SYSTEM 23.48
CENTRAL NERVOUS SYSTEM 15.89
RESPIRATORY SYSTEM 8.53
GASTROINTESTINAL & HEPATOBILIARY SYSTEM 7.84
MUSCULO-SKELETAL SYSTEM 2.43
ONCOLOGY 2.14
GENITO-URINARY SYSTEM 1.8
ENDOCRINE & METABOLIC SYSTEM 1.65
OTHERS 3.59